The Latest Breaking News on Pharma

The drug is used to treat high blood pressure in the lungs

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022. 

Biopharmaceutical company Bristol-Myers Squibb (BMY) has reported sound financials and possesses a solid upside potential. Given its promising fundamentals, this value stock might be an ideal long-term addition to your portfolio. Keep reading….

Ministry of Finance had said that drug manufacturers will have to deduct 10% tax for the value of free samples of medicines

Reuters

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

The bear market has been brutal. Given the trend in inflation and weakening economy, it's unlikely to end soon. For investors, the best strategy is to use the adverse market conditions to scoop up stocks that have a long-term history of compounding earnings. Therefore, investors should consider buying Builders FirstSource…